EASL–ESCMID Position Paper: a review, six months into the pandemic
Six months into the COVID-19 pandemic, an article has been published to provide guidance for physicians involved in the care of patients with chronic liver disease. 5 August 2020 – Geneva, Switzerland:…
Liver enthusiasts who paved the way: 50 years of the Gnomes
Professional societies play a major role in medicine and science. These societies tend to be large, with well-developed administrative structures. An additional model, however, is based on small groups of experts who…
Tribute to Prof. Roger Williams
It is with great sadness that EASL announces the passing of Prof. Roger Williams, a pioneer in liver disease and an inspiration to the world of hepatology. We send our sincere condolences…
EASL declares ongoing commitment to fighting hepatitis
Every year, the World Hepatitis Day brings the world together to focus on the theme of raising awareness about the global burden of viral hepatitis (inflammation of the liver), and to advocate…
Explore the Viral Hepatitis track at Digital ILC 2020
The curative potential of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection have transformed hepatology in recent years. However, the challenge of identifying more people living with HCV remains, and further…
PREDICT Study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology
Researchers at EF Clif identify three different clinical courses for the first time, in patients with acute decompensated cirrhosis without acute-on-chronic liver failure (ACLF). July 14, 2020 – A clinical study led…
Journal of Hepatology ranking climbs, remaining best journal on liver disease
ClarivateTM Analytics released the 2020 update of its Journal Citation Reports©, including the much anticipated 2019 impact factor. EASL’s flagship monthly journal, the Journal of Hepatology, achieved unprecedented results with a 2019…